• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic value of the neutrophil to lymphocyte ratio for cardiovascular diseases: research progress.中性粒细胞与淋巴细胞比值对心血管疾病的预后价值:研究进展
Am J Transl Res. 2025 Feb 15;17(2):1170-1177. doi: 10.62347/KVCV7377. eCollection 2025.
2
Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update.中性粒细胞与淋巴细胞比值(NLR)与心血管疾病:最新进展
Expert Rev Cardiovasc Ther. 2016;14(5):573-7. doi: 10.1586/14779072.2016.1154788. Epub 2016 Mar 4.
3
Evaluating Cardiovascular Risks: The Platelet Lymphocyte Ratio and the Neutrophil Lymphocyte Ratio As High-Risk Heart Score Predictors in Non-ST Elevation Myocardial Infarction (NSTEMI) and Unstable Angina Patients.评估心血管风险:血小板淋巴细胞比率和中性粒细胞淋巴细胞比率作为非ST段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛患者高风险心脏评分预测指标
Cureus. 2024 May 28;16(5):e61279. doi: 10.7759/cureus.61279. eCollection 2024 May.
4
The prognostic value of the combined neutrophil-to-lymphocyte ratio (NLR) and neutrophil-to-platelet ratio (NPR) in sepsis.中性粒细胞与淋巴细胞比值(NLR)和中性粒细胞与血小板比值(NPR)联合在脓毒症中的预后价值。
Sci Rep. 2024 Jul 2;14(1):15075. doi: 10.1038/s41598-024-64469-8.
5
Neutrophil-to-lymphocyte ratio as a predictor of all-cause and cardiovascular mortality in coronary heart disease and hypertensive patients: a retrospective cohort study.中性粒细胞与淋巴细胞比值对冠心病和高血压患者全因及心血管死亡率的预测作用:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Aug 21;15:1442165. doi: 10.3389/fendo.2024.1442165. eCollection 2024.
6
Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery.术前中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与行非心脏手术的冠心病患者的主要不良心脑血管事件相关。
BMC Cardiovasc Disord. 2020 May 18;20(1):230. doi: 10.1186/s12872-020-01500-6.
7
Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study.中性粒细胞与淋巴细胞比值对新发急性冠状动脉综合征患者长期预后的预测效能:一项回顾性队列研究。
BMC Cardiovasc Disord. 2020 Nov 30;20(1):500. doi: 10.1186/s12872-020-01773-x.
8
The neutrophil-to-lymphocyte ratio and mean platelet volume can be associated with severity of valvular involvement in patients with acute rheumatic carditis.中性粒细胞与淋巴细胞比值及平均血小板体积可能与急性风湿性心脏炎患者瓣膜受累的严重程度相关。
Cardiovasc J Afr. 2018;29(5):296-300. doi: 10.5830/CVJA-2018-031. Epub 2018 Sep 10.
9
To Evaluate Platelet Indices, Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Prognostic and Risk Factors in Patients with Coronary Artery Disease.评估血小板指标、血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值作为冠状动脉疾病患者的预后和危险因素。
Indian J Hematol Blood Transfus. 2024 Jan;40(1):103-107. doi: 10.1007/s12288-023-01664-z. Epub 2023 Jun 21.
10
Neutrophil-to-High-Density Lipoprotein Ratio (NHR) and Neutrophil-to-Lymphocyte Ratio (NLR) as prognostic biomarkers for incident cardiovascular disease and all-cause mortality: A comparison study.中性粒细胞与高密度脂蛋白比值(NHR)和中性粒细胞与淋巴细胞比值(NLR)作为新发心血管疾病和全因死亡率的预后生物标志物:一项比较研究。
Am J Prev Cardiol. 2024 Oct 12;20:100869. doi: 10.1016/j.ajpc.2024.100869. eCollection 2024 Dec.

引用本文的文献

1
Biomarkers in Heart Failure: A Review and a Wish.心力衰竭中的生物标志物:综述与期望
Int J Mol Sci. 2025 Aug 20;26(16):8046. doi: 10.3390/ijms26168046.
2
Fibrosis-4 index as a predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease.纤维化-4指数作为慢性肾脏病患者全因死亡率和心血管死亡率的预测指标
PLoS One. 2025 Aug 1;20(8):e0329315. doi: 10.1371/journal.pone.0329315. eCollection 2025.

本文引用的文献

1
Neutrophil-to-lymphocyte ratio as a predictor of all-cause and cardiovascular mortality in coronary heart disease and hypertensive patients: a retrospective cohort study.中性粒细胞与淋巴细胞比值对冠心病和高血压患者全因及心血管死亡率的预测作用:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Aug 21;15:1442165. doi: 10.3389/fendo.2024.1442165. eCollection 2024.
2
Proteomics in Cardiovascular disease.心血管疾病中的蛋白质组学。
Clin Chim Acta. 2024 Apr 15;557:117877. doi: 10.1016/j.cca.2024.117877. Epub 2024 Mar 25.
3
Hematological biomarkers of troponin, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio serve as effective predictive indicators of high-risk mortality in acute coronary syndrome.肌钙蛋白、中性粒细胞与淋巴细胞比值以及单核细胞与淋巴细胞比值等血液生物标志物是急性冠状动脉综合征高危死亡率的有效预测指标。
Biomedicine (Taipei). 2023 Dec 1;13(4):32-43. doi: 10.37796/2211-8039.1425. eCollection 2023.
4
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular and all-cause mortality in hypertension patients.高血压患者中性粒细胞与淋巴细胞比值与心血管及全因死亡率风险的关联
Heliyon. 2024 Mar 7;10(6):e27517. doi: 10.1016/j.heliyon.2024.e27517. eCollection 2024 Mar 30.
5
Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease.蛋白尿:心血管疾病的一个被低估的风险因素。
J Am Heart Assoc. 2024 Jan 16;13(2):e030131. doi: 10.1161/JAHA.123.030131. Epub 2024 Jan 12.
6
Oral Health and Cardiovascular Disease.口腔健康与心血管疾病。
Am J Med. 2024 Apr;137(4):304-307. doi: 10.1016/j.amjmed.2023.11.022. Epub 2023 Dec 22.
7
Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值(NLR)对心力衰竭预后的影响:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2023 Nov 14;23(1):555. doi: 10.1186/s12872-023-03572-6.
8
Update of HDL in atherosclerotic cardiovascular disease.载脂蛋白高密度脂蛋白在动脉粥样硬化性心血管疾病中的研究进展。
Clin Investig Arterioscler. 2023 Nov-Dec;35(6):297-314. doi: 10.1016/j.arteri.2023.10.002. Epub 2023 Nov 7.
9
The role of lactate in cardiovascular diseases.乳酸在心血管疾病中的作用。
Cell Commun Signal. 2023 Nov 3;21(1):317. doi: 10.1186/s12964-023-01350-7.
10
Multiomics tools for improved atherosclerotic cardiovascular disease management.用于改善动脉粥样硬化性心血管疾病管理的多组学工具。
Trends Mol Med. 2023 Dec;29(12):983-995. doi: 10.1016/j.molmed.2023.09.004. Epub 2023 Oct 6.

中性粒细胞与淋巴细胞比值对心血管疾病的预后价值:研究进展

Prognostic value of the neutrophil to lymphocyte ratio for cardiovascular diseases: research progress.

作者信息

Zhang Xinyue, Li Dongyang, Du Yanwei

机构信息

College of Integrated Traditional Chinese and Western Medicine, Changchun University of Chinese Medicine Changchun 130117, Jilin, China.

School of Nursing, Jilin University Changchun 130021, Jilin, China.

出版信息

Am J Transl Res. 2025 Feb 15;17(2):1170-1177. doi: 10.62347/KVCV7377. eCollection 2025.

DOI:10.62347/KVCV7377
PMID:40092102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11909572/
Abstract

The neutrophil to lymphocyte ratio (NLR) is a simple, reliable, and easily accessible composite index that has garnered increasing attention in cardiovascular research. NLR is closely associated with the onset, progression, and prognosis of various cardiovascular diseases. This article reviews the etiological and prognostic roles of NLR in cardiovascular conditions such as coronary atherosclerotic heart disease, hypertension, arrhythmia, heart failure, and valvular heart disease. Studies have shown that NLR is involved in the pathophysiologic processes of these diseases and holds significant predictive value for their prognosis. Additionally, compared to other inflammatory markers, NLR offers advantages such as low cost, repeatability, and the ability to be measured at the community-level primary healthcare settings, thus providing new insight for prognostic prediction in conditions like coronary artery disease, arrhythmia, hypertension, heart failure, and valvular heart disease.

摘要

中性粒细胞与淋巴细胞比值(NLR)是一个简单、可靠且易于获取的综合指标,在心血管研究中受到越来越多的关注。NLR与各种心血管疾病的发生、发展及预后密切相关。本文综述了NLR在冠心病、高血压、心律失常、心力衰竭和心脏瓣膜病等心血管疾病中的病因及预后作用。研究表明,NLR参与了这些疾病的病理生理过程,对其预后具有重要的预测价值。此外,与其他炎症标志物相比,NLR具有成本低、可重复性强以及能够在社区基层医疗环境中进行检测等优势,从而为冠心病、心律失常、高血压、心力衰竭和心脏瓣膜病等疾病的预后预测提供了新的视角。